Original Investigation

Investigation of Anti-Hepatitis Delta Virus and Anti-Hepatitis C Virus in Patients with Hepatitis B Virus Infection

10.5152/imj.2013.30

  • Ayşe İnci
  • Muzaffer Fincancı
  • Cüneyt Müderrisoğlu

Received Date: 11.10.2012 Accepted Date: 02.04.2013 IMJ 2013;14(2):109-111

Objective:

The aim of this study was to determine the prevalence of Hepatitis Delta Virus (HDV) and Hepatitis C Virus (HCV) in patients chronically infected with Hepatitis B Virus (HBV).

Methods:

The study was conducted on chronic hepatitis B patients followed in the Istanbul Training and Research Hospital. The prevalence of anti-HDV and anti-HCV antibodies was investigated in a total of 1339 patients with chronic hepatitis B infection.

Results:

Of the total 1339 patients testing positive for hepatitis B surface antigen (HBsAg), 46 (3.4%)were found to be seropositive for HDV, and 26 (1.9%) were seropositive for HCV.

Conclusion:

We conclude that HDV and HCV infections should be investigated in patients with chronic hepatitis B.

Keywords: Chronic hepatitis B, anti-Hepatitis D Virus (anti-HDV), anti- Hepatitis C Virus (anti-HCV), seroprevalence